Heart attacks remain a significant health concern in the United States. According to the Centers for Disease Control and ...

Glomerulonephritis can affect the normal functioning of the kidneys, with consequences ranging from subtle, easily dismissed ...

Discover the top 3 undervalued Health Care Providers & Services stocks for Thursday, April 24 based on AAII’s Stock Grades.

TNF Pharmaceuticals, Inc. ("TNF" or the "Company"), a clinical stage biopharmaceutical company committed to developing novel therapies for autoimmune and inflammatory conditions, and Renova Health ...

Short term trials with surrogate measures instead of hard outcomes are often used to study chronic diseases. The effects of an intervention may, however, take time to develop and persist after ...

The international community has a golden opportunity to start reining in the escalating, mostly ignored global burden of ...

Having a child recipient and helping someone in need – especially if they knew them – were among the top reasons that people ...

Matt Morgan is a Consultant in Intensive Care Medicine, Honorary Professor for the Public Understanding of Medicine and ...

The Executive Yuan yesterday approved a plan to boost healthcare for 5.35 million Taiwanese with cardiovascular disease and diabetes.

The global continuous renal replacement therapy market revenue was around US$ 1.5 billion in 2021 and is estimated to reach US$ 2.8 billion by 2031, growing at a compound annual growth rate (CAGR) of ...

Learn more about whether Ligand Pharmaceuticals Incorporated or Viatris Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

This is the first study to document the creation of a dedicated inpatient onconephrology service. The researchers highlight some of the challenges and future directions as well.